Sarah Daijogo

Sarah Daijogo, PhD, is a seasoned professional in the field of biological sciences with extensive experience in quality control and method development for infectious disease vaccines. Currently serving as the Manager of Quality Control Viral Vector at Avid Bioservices since April 2023, Sarah previously held the position of Senior Manager at Emergent BioSolutions and Manager of Method Development at Q2 Solutions from 2009 to 2022. A proven leader, Sarah has successfully managed over 38 pre-clinical to phase III clinical studies within a regulated clinical research organization, emphasizing excellence in method development, qualification, validation, and clinical testing. Sarah's academic background includes a PhD and BS in Biological Sciences from the University of California, Irvine, where research focused on poliovirus translation and replication, as well as ligand interaction with nuclear hormone receptors.